Skip to content

Enhancing Smoking Cessation Via Telehealth Options in Primary Care

Hybrid Type 1 Effectiveness-Implementation Trial of a Proactive Smoking Cessation Electronic Visit for Scalable Delivery Via Primary Care

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05493254
Acronym
E-STOP
Enrollment
672
Registered
2022-08-09
Start date
2022-08-31
Completion date
2026-12-31
Last updated
2026-03-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Smoking Cessation

Brief summary

The purpose of this research study is to evaluate an electronic visit (e-visit) for smoking cessation. Participants will be randomly assigned to receive either the smoking cessation e-visit or not. The e-visit will look similar to an online questionnaire asking about smoking history, motivation to quit, and preferences for medications for quitting smoking. Participants may receive a prescription for a smoking cessation medication as an outcome of the e-visit, if randomized to the e-visit group, but there is no requirement to take any medication. This study consists of questionnaires and breath samples provided at 4 separate time points throughout the study. Participation in this study will take about 24 weeks.

Interventions

electronic visits (e-visits) for smoking cessation

BEHAVIORALTreatment As Usual

Information about the state quitline and about the importance of quitting smoking and a recommendation to contact one's PCP to schedule a medical visit to discuss quitting smoking.

Sponsors

Medical University of South Carolina
Lead SponsorOTHER
National Cancer Institute (NCI)
CollaboratorNIH

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

1. current smoking, defined as 1+ cigarettes/day, for 20+ days out of the last 30 for the last 6+ months 2. age 18+ 3. enrolled in MyChart or willing to enroll 4. possess a valid e-mail address that is checked daily 5. owner of an iOS or Android smartphone to provide remote CO 6. have a valid mailing address 7. English fluency

Exclusion criteria

1\) Use of an FDA-approved cessation medication in the last 7 days

Design outcomes

Primary

MeasureTime frameDescription
Number of participants who utilized smoking cessation treatmentMonth 1Number of participants who utilized smoking cessation treatment since last assessment.
Cigarettes smokingMonth 1Cigarettes per day reduction greater than 50%
Quit attemptsMonth 1Quit attempts since last contact
Seven-day point prevalence abstinenceMonth 1Participant has not had a cigarette in the past 7 days
E-visit AcceptabilityMonth 1The e-visit will be considered acceptable if the average score on the Acceptability of Intervention Measure (AIM) is greater than or equal to 4.
E-visit AdoptionMonth 1Patients prescribed a medication who obtain their medication

Countries

United States

Contacts

CONTACTNoelle E Natale
natalen@musc.edu843-876-2426

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 6, 2026